Core Viewpoint - A class action securities lawsuit has been filed against Reddit, Inc. for alleged securities fraud affecting investors between October 29, 2024, and May 20, 2025 [1][2]. Group 1: Lawsuit Details - The complaint alleges that the defendants made false statements regarding the impact of changes in Google Search's algorithm, which led to a significant reduction in traffic to Reddit [2]. - It is claimed that the defendants were aware that users were finding answers directly on Google Search, leading to a decrease in visits to Reddit, contrary to their public statements about user rates and advertising revenues [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until August 18, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - Iovance Biotherapeutics, Inc. is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between May 9, 2024, and May 8, 2025 [1][2]. Group 1: Allegations and Financial Impact - The lawsuit claims that Iovance provided misleadingly positive statements while concealing material adverse facts about its growth potential and ability to meet demand for its treatments [2]. - On July 25, 2024, Iovance announced a reduction in its revenue guidance for fiscal year 2024, attributing this to maintenance issues, lower-than-expected Proleukin sales, and a variable pace of treatment initiation at approved centers [2]. - Following the announcement, Iovance's stock price plummeted from $3.17 per share on May 8, 2025, to $1.75 per share on May 9, 2025, marking a decline of approximately 44.8% in one day [2]. Group 2: Legal Proceedings and Participation - Investors who suffered losses during the specified period have until July 14, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - Quantum computing stocks experienced significant activity, highlighted by a successful stock offering and positive analyst coverage across several companies in the sector [1] Group 1: D-Wave Quantum (QBTS) - D-Wave Quantum, Inc. completed a $400 million common stock offering at an average price of $15.18 per share [2] - Analyst Troy Jensen from Cantor Fitzgerald initiated coverage with an Overweight rating and a $20 price target, indicating optimism about the company's future [2][3] - Jensen believes D-Wave is in the early stages of commercializing its technology and could capture 15% of the quantum hardware, software, and services market by 2035 [3] Group 2: Rigetti Computing (RGTI) - Rigetti Computing, Inc. also received an Overweight rating from Cantor Fitzgerald, with a bullish price target of $15 [4] - The company's share price has surged approximately 1,008% over the past 52 weeks, recovering from challenging years in 2022 and 2023 [4] - Rigetti's partnership with Quanta Computer is expected to enhance the development and commercialization of superconducting quantum computing [5] Group 3: IonQ (IONQ) - IonQ, Inc. shares increased by about 11% this week, receiving a Buy rating and a $45 price forecast from Cantor Fitzgerald [6] - The company reported a strong financial position, ending Q1 2025 with nearly $700 million in cash after a $373 million equity raise [6] Group 4: Quantum Computing, Inc. (QUBT) - Quantum Computing, Inc. received a Neutral rating from Cantor Fitzgerald with a $15 price target, which is below the current stock price of $20 [7] - Despite the Neutral rating, QUBT stock has shown strong performance, gaining 67.5% over the past month and over 4,600% in the past year [7]

Core Viewpoint - A class action securities lawsuit has been filed against Digimarc Corporation, alleging securities fraud that negatively impacted investors between May 3, 2024, and February 26, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Digimarc's management made false statements regarding a significant commercial partner's contract renewal, which would not occur on the same terms [2]. - It is alleged that due to this non-renewal, Digimarc would need to renegotiate the large commercial contract, adversely affecting the company's subscription revenue and annual recurring revenue [2]. - The complaint asserts that the positive statements made by the defendants about the company's business and prospects were materially misleading or lacked a reasonable basis [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until July 7, 2025, to request the Court to appoint them as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has a strong track record in high-stakes securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

周四（7月3日）北美尾盘，加拿大10年期基准国债收益率涨2.6个基点，报3.385%，北京时间20:30发布 美国非农就业报告时从3.330%一线拉升至接近3.390%的水平。 加拿大标普/TSX综合指数收涨0.58%，报27026.24点，继续创收盘历史新高，4月上旬以来持续震荡上行 ——4月8日收盘以来累计上涨约20.08%；小盘股指收涨0.27%，报917.94点，也连续第二个交易日创收 盘历史新高，4月8日收盘以来累涨超29.17%。 两年期加债收益率涨2.3个基点，报2.689%，非农就业数据发布时从2.650%拉升至2.700%上方；五年期 加债收益率涨2.7个基点，报2.942%。 ...

Core Viewpoint - USCB Financial Holdings, Inc. is set to report its financial results for the quarter ended June 30, 2025, on July 24, 2025, after market close [1] Group 1: Financial Reporting - The financial results will be discussed in a conference call on July 25, 2025, at 11:00 am Eastern Time [2] - The call will feature key executives including the Chairman, President, and CEO, Luis de la Aguilera, along with the CFO, Robert Anderson, and the Chief Credit Officer, William Turner [1] Group 2: Company Overview - USCB Financial Holdings, Inc. is the bank holding company for U.S. Century Bank, established in 2002 [4] - U.S. Century Bank is one of the largest community banks in Miami and Florida, rated 5-Stars by BauerFinancial [4] - The bank offers a wide range of financial products and services and supports various community organizations [4]

Core Viewpoint - A class action securities lawsuit has been filed against Compass Group Diversified Holdings, LLC due to alleged securities fraud affecting investors between February 24, 2022, and May 7, 2025 [1][2] Group 1: Allegations and Impact - The lawsuit claims that Compass Diversified failed to disclose effective internal controls over financial reporting and critical information regarding its subsidiary, Lugano Holding, Inc., which had undisclosed financing arrangements and irregularities in sales, cost of sales, inventory, and accounts receivable [2] - On May 7, 2025, Compass announced that its financial statements for fiscal 2024 could no longer be relied upon due to an internal investigation into Lugano, leading to a significant drop in stock price from $17.25 per share to $6.55 per share within one day [2] Group 2: Legal Proceedings - Investors who suffered losses during the relevant time frame have until July 8, 2025, to request to be appointed as lead plaintiff in the class action lawsuit [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4]

Core Insights - Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on developing gene therapies for inherited retinal diseases and small molecule therapies for other ophthalmic disorders [1][3] - The company granted equity awards to two new non-executive employees as an inducement for employment, consisting of stock options and restricted stock units (RSUs) [1][2] Equity Awards Details - The equity awards include stock options for 240,000 shares and 150,000 RSUs, with the stock options having an exercise price of $0.94, equal to the closing price on the grant date [2] - Stock options vest over four years, with 25% vesting on the one-year anniversary and the remaining 75% vesting quarterly thereafter; RSUs vest in four equal installments on each anniversary of the grant date [2] Company Pipeline - Opus Genetics is developing AAV-based gene therapies targeting inherited retinal diseases such as Leber congenital amaurosis (LCA), bestrophinopathy, and retinitis pigmentosa [3] - The lead candidate, OPGx-LCA5, is in a Phase 1/2 trial for LCA5-related mutations and has shown promising early results [3] - Additional programs include OPGx-BEST1 for BEST1-related retinal degeneration and a Phase 3-ready small molecule therapy for diabetic retinopathy, developed under a Special Protocol Assessment with the FDA [3] - The company is also advancing Phentolamine Ophthalmic Solution 0.75%, which is approved for one indication and is being studied in two Phase 3 programs for presbyopia and dim light vision disturbances [3]

Dakota Gold Announces Date for Webcast Conference Call to Review the Initial Assessment with Cash Flow for Richmond HillJuly 03, 2025 4:30 PM EDT | Source: Dakota Gold Corp.Lead, South Dakota--(Newsfile Corp. - July 3, 2025) - Dakota Gold Corp. (NYSE American: DC) ("Dakota Gold" or the "Company") is pleased to announce the expected release of the S-K 1300 Initial Assessment Technical Report with economic analysis ("S-K 1300 Initial Assessment with Cash Flow", "IACF" or "Report") for the Richmo ...

NORWALK, Conn., July 3, 2025 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced a leadership transition within its North America operations. Mr. Cameron "Mac" Moore, Executive Vice President - North America, has departed the Company, and Mr. M. Jahangir Alam has been appointed as his successor, effective immediately.About M. Jahangir AlamM. Jahangir Alam is a seasoned leader in the North Am ...